DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $683,823,888 | -1.2% | 2,756,243 | -4.4% | 1.38% | -4.2% |
| Q2 2023 | $692,286,000 | +2.5% | 2,884,525 | +7.7% | 1.44% | -10.0% |
| Q1 2023 | $675,231,291 | +6.8% | 2,679,064 | +11.2% | 1.60% | -6.8% |
| Q4 2022 | $632,040,014 | +4.2% | 2,409,883 | +2.6% | 1.72% | -11.7% |
| Q3 2022 | $606,643,000 | +526.6% | 2,348,688 | +515.0% | 1.95% | +356.1% |
| Q2 2022 | $96,818,000 | -3.7% | 381,895 | +11.4% | 0.43% | +7.8% |
| Q1 2022 | $100,565,000 | +1.5% | 342,839 | +9.2% | 0.40% | +0.8% |
| Q4 2021 | $99,121,000 | +17.8% | 313,914 | +13.6% | 0.39% | -5.1% |
| Q3 2021 | $84,130,000 | +24.2% | 276,345 | +9.5% | 0.42% | +12.5% |
| Q2 2021 | $67,712,000 | +35.9% | 252,319 | +14.0% | 0.37% | +12.8% |
| Q1 2021 | $49,834,000 | +18.5% | 221,405 | +17.0% | 0.33% | +0.6% |
| Q4 2020 | $42,045,000 | +10.7% | 189,271 | +7.3% | 0.32% | -6.9% |
| Q3 2020 | $37,971,000 | +45.1% | 176,339 | +19.2% | 0.35% | +16.7% |
| Q2 2020 | $26,166,000 | +46.3% | 147,973 | +14.5% | 0.30% | +8.3% |
| Q1 2020 | $17,885,000 | -10.0% | 129,216 | +0.2% | 0.28% | +6.6% |
| Q4 2019 | $19,881,000 | +19.1% | 128,975 | +11.5% | 0.26% | -4.8% |
| Q3 2019 | $16,699,000 | +6.9% | 115,621 | +5.8% | 0.27% | +1.9% |
| Q2 2019 | $15,621,000 | +34.9% | 109,298 | +24.6% | 0.27% | +12.2% |
| Q1 2019 | $11,578,000 | +44.5% | 87,697 | +6.9% | 0.24% | +17.8% |
| Q4 2018 | $8,011,000 | -14.7% | 82,065 | -5.0% | 0.20% | +4.7% |
| Q3 2018 | $9,389,000 | +8.7% | 86,406 | -1.3% | 0.19% | +1.0% |
| Q2 2018 | $8,639,000 | -0.2% | 87,548 | -1.0% | 0.19% | -5.0% |
| Q1 2018 | $8,657,000 | -4.2% | 88,417 | -8.3% | 0.20% | +2.6% |
| Q4 2017 | $9,036,000 | +10.7% | 96,462 | +1.3% | 0.20% | +2.1% |
| Q3 2017 | $8,166,000 | +5.8% | 95,194 | +4.1% | 0.19% | +1.6% |
| Q2 2017 | $7,718,000 | -11.5% | 91,462 | -10.3% | 0.19% | -5.0% |
| Q1 2017 | $8,718,000 | +12.5% | 101,933 | +3.7% | 0.20% | +5.9% |
| Q4 2016 | $7,747,000 | +3.6% | 98,341 | +3.1% | 0.19% | +1.1% |
| Q3 2016 | $7,478,000 | -71.6% | 95,393 | -63.4% | 0.19% | -72.9% |
| Q2 2016 | $26,300,000 | +4.0% | 260,395 | -2.3% | 0.69% | +0.3% |
| Q1 2016 | $25,292,000 | -4.6% | 266,629 | -6.6% | 0.68% | -10.5% |
| Q4 2015 | $26,523,000 | +6.8% | 285,564 | -2.0% | 0.76% | -2.6% |
| Q3 2015 | $24,834,000 | +24.1% | 291,441 | +24.6% | 0.78% | +27.7% |
| Q2 2015 | $20,015,000 | +6.0% | 233,845 | +5.1% | 0.61% | +9.8% |
| Q1 2015 | $18,885,000 | +25.3% | 222,439 | +26.6% | 0.56% | +20.2% |
| Q4 2014 | $15,066,000 | +26.0% | 175,761 | +11.6% | 0.46% | +29.5% |
| Q3 2014 | $11,961,000 | -19.6% | 157,425 | -16.6% | 0.36% | -6.0% |
| Q2 2014 | $14,868,000 | +7.1% | 188,845 | +2.1% | 0.38% | +3.2% |
| Q1 2014 | $13,876,000 | +12.8% | 185,009 | +15.1% | 0.37% | +4.8% |
| Q4 2013 | $12,303,000 | +2.5% | 160,698 | -7.2% | 0.35% | +12.8% |
| Q3 2013 | $12,004,000 | +29.2% | 173,175 | +18.0% | 0.31% | +18.6% |
| Q2 2013 | $9,288,000 | – | 146,731 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |